InvestorsHub Logo
Followers 2
Posts 1472
Boards Moderated 0
Alias Born 07/20/2016

Re: huskercatman123 post# 89295

Tuesday, 01/01/2019 1:21:18 PM

Tuesday, January 01, 2019 1:21:18 PM

Post# of 108192
I think it's safe to say the treatment(s) is efficacious. Whether or not the company can successfully bring it to market is another thing. There have been many, many missteps along the way and I still believe the company was worse off than we were led to believe when KB came in. He has tried to stop the bleeding and, if the FDA goes along with the revision of the AIM2CERV, I think we have a shot of being a commercial company. Once again though, timeline targets have not been met. We'll see what happens this year. GLTA.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent ADXS News